Mumbai, Maharashtra, India, Monday, September 30, 2013 -- (Business Wire India) Abbott has been named the ‘Multinational Pharmaceutical Company of the Year' for the third consecutive year at the 2013 Frost & Sullivan India Healthcare Excellence Awards held in Mumbai on Friday. The prestigious annual award from Frost and Sullivan acknowledges best practices in the healthcare industry and measures companies on parameters such as revenue and market share growth, geographical and product line expansion, visibility of the company, value-added services, strategic and technological innovation, and clinical excellence. Abbott was recognised for its outstanding performance against these criteria in 2012-2013. With a heritage of over 100 years in India, Abbott is committed to investing in building its local capabilities — through people, infrastructure, innovation and partnerships — while benefiting from being a part of one of the world's leading healthcare companies. Congratulating Abbott on the award, Sandeep Sinha, Director, Healthcare and Life Sciences Practice, Frost & Sullivan, said, "Our analysis shows that Abbott India's success is a combination of a diversified product portfolio, focused execution, and attention to fulfilling the unmet health needs of patients. Abbott's performance and growth represents continuous efforts in terms of innovation, accessibility, and affordability of medicine to patients at large in India." Commenting on the award, Rehan A. Khan, Managing Director, Abbott India Ltd, said, “As one of India's oldest healthcare companies, we take pride in applying our knowledge and expertise to help address the country's most relevant healthcare challenges and needs. Abbott is honoured to be recognised for our commitment to improving access to high-quality and affordable, branded generic medicines that have been successfully treating patients for many years.” Abbott is one of the leading healthcare companies in India, providing consumers with a diverse range of established pharmaceuticals, nutritional products, medical devices, and diagnostic tests. Also ranked the number one company in the Indian pharmaceutical market1, Abbott has 20 pharmaceutical brands in the Top 300 in the country and has substantial expertise and a strong presence in important therapy areas like cardio-metabolic, gastroenterology, women's health, neurosciences, cough management, antibiotics, pain and dermatology. About the Frost & Sullivan Annual India Healthcare Excellence Awards 2013 The coveted Frost & Sullivan India Healthcare Excellence Awards are presented to companies that demonstrate best practices in the Indian Healthcare and Life sciences industry. These awards are a boost for organizations not only because of the recognition they bring, but also in terms of industry standings. The award categories span across various healthcare segments such as Pharmaceuticals and Biotechnology, Medical Technologies, Healthcare Delivery Services and Special Awards. The awards program follows a rigorous methodology to recognize superior planning and execution of product launches, strategic alliances, distribution strategies, technological innovations, customer services, healthcare delivery services, and mergers and acquisitions. A host of other crucial factors such as leadership, strategy, growth, service, innovation, integration, marketing, financial performance, and development are also considered as part of the award methodology. These awards are in keeping with Frost & Sullivan's commitment to recognize innovative growth strategies and solutions adopted by the best companies in the healthcare industry. About Abbott Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people. In India, Abbott has more than 12,000 employees working in manufacturing, research and development, logistics, sales and marketing and is headquartered in Mumbai. Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews. 1 ORG IMS, Secondary Sales Audit July 2013 To view the photograph, please click on the link given below: Mr. Rehan Khan, MD, Abbott India, receiving the F&S award at the hands of DG Shah, Secretary-General, Indian Pharmaceutical Alliance Media contact details Varsha Chainani, Dir, Public Affairs, Abbott, +91 9987340055, email@example.com Contributed via: Bloomberg Publisher WEB Service Provider ID: 28e3151d98a34c97b5cf4b0fbb64e77a -0- Oct/01/2013 10:08 GMT
Abbott Named India's Top Multinational Pharmaceutical Company
Press spacebar to pause and continue. Press esc to stop.